Literature DB >> 8307341

The impact of a meditation-based stress reduction program on fibromyalgia.

K H Kaplan1, D L Goldenberg, M Galvin-Nadeau.   

Abstract

Fibromyalgia is a chronic illness characterized by widespread pain, fatigue, sleep disturbance, and resistance to treatment. The purpose of this study was to evaluate the effectiveness of a meditation-based stress reduction program on fibromyalgia. Seventy-seven patients meeting the 1990 criteria of the American College of Rheumatology for fibromyalgia took part in a 10-week group outpatient program. Therapists followed a carefully defined treatment approach and met weekly to further promote uniformity. Patients were evaluated before and after the program. Initial evaluation included a psychiatric structured clinical interview (SCID). Outcome measures included visual analog scales to measure global well-being, pain, sleep, fatigue, and feeling refreshed in the morning. Patients also completed a medical symptom checklist, SCL-90-R, Coping Strategies Questionnaire, Fibromyalgia Impact Questionnaire, and the Fibromyalgia Attitude Index. Although the mean scores of all the patients completing the program showed improvement, 51% showed moderate to marked improvement and only they were counted as "responders." These preliminary findings suggest that a meditation-based stress reduction program is effective for patients with fibromyalgia.

Entities:  

Mesh:

Year:  1993        PMID: 8307341     DOI: 10.1016/0163-8343(93)90020-o

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  45 in total

1.  Therapeutic mechanisms of a mindfulness-based treatment for IBS: effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations.

Authors:  Eric L Garland; Susan A Gaylord; Olafur Palsson; Keturah Faurot; J Douglas Mann; William E Whitehead
Journal:  J Behav Med       Date:  2011-12-08

2.  Couples coping with multiple sclerosis: a dyadic perspective on the roles of mindfulness and acceptance.

Authors:  Kenneth I Pakenham; Christina Samios
Journal:  J Behav Med       Date:  2012-06-12

Review 3.  The effects of meditation-based interventions on the treatment of fibromyalgia.

Authors:  Elisa H Kozasa; Luiza H Tanaka; Carlos Monson; Stephen Little; Frederico Camelo Leao; Mario P Peres
Journal:  Curr Pain Headache Rep       Date:  2012-10

4.  Mindfulness-Based Stress Reduction for Adolescents with Functional Somatic Syndromes: A Pilot Cohort Study.

Authors:  Ather Ali; Theresa R Weiss; Anne Dutton; Douglas McKee; Kim D Jones; Susmita Kashikar-Zuck; Wendy K Silverman; Eugene D Shapiro
Journal:  J Pediatr       Date:  2017-01-12       Impact factor: 4.406

Review 5.  [Does meditation improve the quality of life for patients living with cancer?].

Authors:  Pascal Lamanque; Serge Daneault
Journal:  Can Fam Physician       Date:  2006-04       Impact factor: 3.275

Review 6.  Complementary and integrative methods in fibromyalgia.

Authors:  Ather Ali; Paul L McCarthy
Journal:  Pediatr Rev       Date:  2014-12

Review 7.  Wellness programs: a review of the evidence.

Authors:  D Watt; S Verma; L Flynn
Journal:  CMAJ       Date:  1998-01-27       Impact factor: 8.262

8.  Mindfulness meditation for symptom reduction in fibromyalgia: psychophysiological correlates.

Authors:  Elizabeth Lush; Paul Salmon; Andrea Floyd; Jamie L Studts; Inka Weissbecker; Sandra E Sephton
Journal:  J Clin Psychol Med Settings       Date:  2009-03-10

9.  Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology.

Authors:  Jarred W Younger; Alex J Zautra; Eric T Cummins
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

10.  Mindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial.

Authors:  Susan A Gaylord; William E Whitehead; Rebecca S Coble; Keturah R Faurot; Olafur S Palsson; Eric L Garland; William Frey; John Douglas Mann
Journal:  BMC Complement Altern Med       Date:  2009-07-28       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.